VistaGen Therapeutics Inc (VTGN) reported Loss for its third quarter that increased from last year but beat the Street estimates.
The company's earnings totaled -$14.09 million, or -$0.46 per share. This compares with -$6.35 million, or -$0.22 per share, last year.
Analysts on average had expected the company to earn -$0.52 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period fell 43.9% to $0.23 million from $0.41 million last year.
VistaGen Therapeutics Inc earnings at a glance (GAAP) :
-Earnings: -$14.09 Mln. vs. -$6.35 Mln. last year.
-EPS: -$0.46 vs. -$0.22 last year.
-Revenue: $0.23 Mln vs. $0.41 Mln last year.
For comments and feedback: editorial@rttnews.com